292 related articles for article (PubMed ID: 26233926)
1. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.
Rawson R; Yang T; Newbury RO; Aquino M; Doshi A; Bell B; Broide DH; Dohil R; Kurten R; Aceves SS
J Allergy Clin Immunol; 2016 Sep; 138(3):791-800.e4. PubMed ID: 27212082
[TBL] [Abstract][Full Text] [Related]
3. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
[TBL] [Abstract][Full Text] [Related]
5. Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis.
Wang J; Park JY; Huang R; Souza RF; Spechler SJ; Cheng E
Gastrointest Endosc; 2018 May; 87(5):1207-1214.e3. PubMed ID: 29309779
[TBL] [Abstract][Full Text] [Related]
6. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
[TBL] [Abstract][Full Text] [Related]
7. MMPs-2 and -14 Are Elevated in Eosinophilic Esophagitis and Reduced Following Topical Corticosteroid Therapy.
Beppu L; Yang T; Luk M; Newbury RO; Palmquist J; Dohil R; Kurten RC; Broide DH; Aceves SS
J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):194-9. PubMed ID: 25539192
[TBL] [Abstract][Full Text] [Related]
8. Smad3-deficient mice have reduced esophageal fibrosis and angiogenesis in a model of egg-induced eosinophilic esophagitis.
Cho JY; Doshi A; Rosenthal P; Beppu A; Miller M; Aceves S; Broide D
J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):10-6. PubMed ID: 24590208
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.
Schoepfer AM; Simko A; Bussmann C; Safroneeva E; Zwahlen M; Greuter T; Biedermann L; Vavricka S; Godat S; Reinhard A; Saner C; Maye H; Sempoux C; Brunel C; Blanchard C; Simon D; Simon HU; Straumann A
Am J Gastroenterol; 2018 Mar; 113(3):348-357. PubMed ID: 29336433
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.
Beppu LY; Anilkumar AA; Newbury RO; Dohil R; Broide DH; Aceves SS
J Allergy Clin Immunol; 2014 Nov; 134(5):1100-1107.e4. PubMed ID: 24835503
[TBL] [Abstract][Full Text] [Related]
12. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
13. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
[TBL] [Abstract][Full Text] [Related]
15. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
Dohil R; Newbury R; Fox L; Bastian J; Aceves S
Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of eosinophilic esophagitis.
Gonsalves NP; Aceves SS
J Allergy Clin Immunol; 2020 Jan; 145(1):1-7. PubMed ID: 31910983
[TBL] [Abstract][Full Text] [Related]
17. Remodeling and fibrosis in chronic eosinophil inflammation.
Aceves SS
Dig Dis; 2014; 32(1-2):15-21. PubMed ID: 24603375
[TBL] [Abstract][Full Text] [Related]
18. Esophageal remodeling in eosinophilic esophagitis: Relationships to luminal captured biomarkers of inflammation and periostin.
Muir AB; Ackerman SJ; Pan Z; Benitez A; Burger C; Spergel JM; Furuta GT; Rothman J; Wilkins BJ; Arnold MA; Dolinsky L; Grozdanovic M; Menard-Katcher C
J Allergy Clin Immunol; 2022 Sep; 150(3):649-656.e5. PubMed ID: 35405206
[TBL] [Abstract][Full Text] [Related]
19. Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.
Bolton SM; Kagalwalla AF; Arva NC; Wang MY; Amsden K; Melin-Aldana H; Dellon ES; Bryce PJ; Wershil BK; Wechsler JB
Am J Gastroenterol; 2020 Feb; 115(2):224-233. PubMed ID: 31913192
[TBL] [Abstract][Full Text] [Related]
20. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
